ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $149,000 | +27.4% | 36,284 | +10.8% | 0.00% | – |
| Q4 2021 | $117,000 | +30.0% | 32,749 | +50.2% | 0.00% | – |
| Q1 2021 | $90,000 | +73.1% | 21,799 | +66.3% | 0.00% | – |
| Q4 2020 | $52,000 | -16.1% | 13,105 | -42.5% | 0.00% | – |
| Q2 2020 | $62,000 | -82.9% | 22,801 | -79.3% | 0.00% | -100.0% |
| Q2 2019 | $362,000 | +583.0% | 110,029 | +314.1% | 0.00% | – |
| Q4 2017 | $53,000 | +178.9% | 26,569 | +136.1% | 0.00% | – |
| Q3 2016 | $19,000 | -85.7% | 11,254 | -91.1% | 0.00% | -100.0% |
| Q2 2016 | $133,000 | +329.0% | 126,474 | +755.1% | 0.00% | – |
| Q2 2015 | $31,000 | -68.4% | 14,791 | -72.4% | 0.00% | -100.0% |
| Q3 2014 | $98,000 | – | 53,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WILLIAM HARRIS INVESTORS INC | 2,338,735 | $6,244,000 | 1.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,603,703 | $25,642,000 | 1.03% |
| Broadfin Capital, LLC | 6,100,000 | $16,288,000 | 0.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,088,675 | $2,907,000 | 0.58% |
| MARINER INVESTMENT GROUP LLC | 296,477 | $792,000 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 36,500 | $97,000 | 0.14% |
| Peregrine Asset Advisers, Inc. | 53,034 | $142,000 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,165,738 | $3,101,000 | 0.12% |
| Avenir Corp | 341,035 | $911,000 | 0.08% |
| Brown Advisory Securities, LLC | 50,550 | $135,000 | 0.05% |